Back to the main directory
EarningsReview / Equity
- Yara (Buy, TP: NOK425.00) - Capex cuts set to boost dividends by DnB Markets
- Camurus (Buy, TP: SEK630.00) - US royalties the big unknown by DnB Markets
- Johan Sverdrup water cut edging higher by DnB Markets
- GN Store Nord - Transformation continues with Consumer exit by Danske Bank Equity Research
- ASR Investor Day preview - New group, same attractions by BNP Paribas Exane
- Half time report by BNP Paribas Exane
- Bunge buyout: sensible price, but do we want to own the assets? by BNP Paribas Exane
- PulluP Entertainment - Un fort rebond attendu en 24/25 by MidCap Partners
- Schibsted - What’s not to like? by Danske Bank Equity Research
- PulluP Entertainment - A Strong Rebound Expected in FY 24/25 by MidCap Partners
- INVEST SECURITIES - TME PHARMA : Meilleure visibilité grâce à une AK sécurisée - ACHAT, OC 0,49€ vs 0,61€ by Invest Securities
- INVEST SECURITIES - CAPGEMINI : Publication rassurante d'Accenture - ACHAT, OC 248€ by Invest Securities
- Cereno Scientific - CS014 (second asset) crosses into the clinic by Edison Investment Research
- FQ3’24 postview: Business bottoming setting up FY25 rebound by BNP Paribas Exane
- 广汇汽车（600297 CH） by HSBC
- Non material data changes by BNP Paribas Exane
- First Look on FQ1 EPS beat by BNP Paribas Exane
- Amoeba - Focused on high-value opportunities by Edison Investment Research
- Reassuring on the downside, waiting for the upside by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Controlling what they can, but we still have some concerns by BNP Paribas Exane
- Salmon Evolution (Buy, TP: NOK9.90) - Platform for growth by DnB Markets
- Valuation and market update by DnB Markets